UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus

Cell reports (Cambridge), 2018-04, Vol.23 (1), p.50-57

2018

Volltextzugriff (PDF)

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

Scientific reports, 2015-10, Vol.5 (1), p.15400-15400, Article 15400

2015

Volltextzugriff (PDF)

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma

Haematologica (Roma), 2022-03, Vol.107 (10), p.2395-2407

2022

Volltextzugriff (PDF)

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

Journal for immunotherapy of cancer, 2019-09, Vol.7 (1), p.243-243, Article 243

2019

Volltextzugriff (PDF)

A novel role for an old target: CD45 for breast cancer immunotherapy

Oncoimmunology, 2021-01, Vol.10 (1), p.1929725-1929725

2021

Volltextzugriff (PDF)

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

Frontiers in immunology, 2017-09, Vol.8, p.1212-1212

2017

Volltextzugriff (PDF)

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles

ACS omega, 2021-11, Vol.6 (43), p.28507-28514

2021

Volltextzugriff (PDF)

The mutational status of p53 can influence its recognition by human T-cells

Oncoimmunology, 2017-04, Vol.6 (4), p.e1285990-e1285990

2017

Volltextzugriff (PDF)

Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides

Journal for immunotherapy of cancer, 2019-05, Vol.7 (1), p.135-9, Article 135

2019

Volltextzugriff (PDF)

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

Frontiers in medicine, 2021-08, Vol.8, p.675963-675963

2021

Volltextzugriff (PDF)

Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells

Molecular carcinogenesis, 2020-07, Vol.59 (7), p.713-723

2020

Volltextzugriff (PDF)

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

The Journal of clinical investigation, 2015-10, Vol.125 (10), p.3981-3991

2015

Volltextzugriff (PDF)

T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer

Advanced drug delivery reviews, 2019-02, Vol.141, p.23-40

2019

Volltextzugriff (PDF)

Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis

Clinical cancer research, 2022-12, Vol.28 (23), p.5156-5166

2022

Volltextzugriff (PDF)

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1708-1716

2012

Volltextzugriff (PDF)

Human gamma delta T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells

The Journal of immunology (1950), 2012-02, Vol.188 (4), p.1708-1716

2012

Volltextzugriff (PDF)

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity

The Journal of immunology (1950), 2012-06, Vol.188 (11), p.5538-5546

2012

Volltextzugriff (PDF)

Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation

Nanomedicine, 2022-11, Vol.46, p.102596-102596, Article 102596

2022

Volltextzugriff (PDF)

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond

Cancer research (Chicago, Ill.), 2007-04, Vol.67 (8), p.3898-3903

2007

Volltextzugriff (PDF)

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

The Journal of clinical investigation, 2021-10, Vol.131 (20)

2021

Volltextzugriff (PDF)

Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

Cancer immunology research, 2016-08, Vol.4 (8), p.669-678

2016

Volltextzugriff (PDF)

Genetically modulating T-cell function to target cancer

Seminars in cancer biology, 2012-02, Vol.22 (1), p.14-22

2012

Volltextzugriff (PDF)

Enhanced antitumor activity mediated by human 4‐1BB‐engineered T cells

International journal of cancer, 2013-12, Vol.133 (12), p.2903-2913

2013

Volltextzugriff (PDF)

MHC-multimer guided isolation of neoepitopes specific T cells as a potent-personalized cancer treatment strategy

Oncoimmunology, 2016-07, Vol.5 (7), p.e1159370-e1159370

2016

Volltextzugriff (PDF)

How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer

Frontiers in immunology, 2012, Vol.3, p.186-186

2012

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Aktive Filter

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(44)
Französisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Increased RNA Editing May Provide a Source for Autoantigens in Systemic Lupus Erythematosus

In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications

Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma

A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function

A novel role for an old target: CD45 for breast cancer immunotherapy

Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor

Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles

The mutational status of p53 can influence its recognition by human T-cells

Level of neo-epitope predecessor and mutation type determine T cell activation of MHC binding peptides

Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

Targeting glycosylated antigens on cancer cells using siglec‐7/9‐based CAR T‐cells

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes

T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer

Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells

Human gamma delta T Lymphocytes Are Licensed for Professional Antigen Presentation by Interaction with Opsonized Target Cells

Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidity

Multifunctional nanoprobe for real-time in vivo monitoring of T cell activation

Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens

Genetically modulating T-cell function to target cancer

Enhanced antitumor activity mediated by human 4‐1BB‐engineered T cells

MHC-multimer guided isolation of neoepitopes specific T cells as a potent-personalized cancer treatment strategy

How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer

Aktive Filter

Suchergebnisse filtern